Published in AIDS on July 09, 1999
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev (2001) 2.87
Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis (2010) 2.60
Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS (2000) 2.32
The effect of tuberculosis on mortality in HIV positive people: a meta-analysis. PLoS One (2010) 1.46
Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. J Infect Dis (2005) 1.35
Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. PLoS One (2013) 1.35
Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence. AIDS (2008) 1.16
Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy. PLoS One (2013) 0.95
Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency virus type 1 infection and pulmonary tuberculosis: implications for pathogenesis. J Clin Immunol (2001) 0.91
Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively. Clin Exp Immunol (2000) 0.88
Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria. Ann Thorac Med (2015) 0.82
Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count. PLoS One (2015) 0.77
Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013. J Int AIDS Soc (2016) 0.76
AIDS as a zoonosis: scientific and public health implications. Science (2000) 8.28
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health (2001) 6.29
The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. Am J Public Health (2001) 5.32
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 3.59
Expansion of surveillance case definition for AIDS in resource-poor countries. Lancet (1993) 2.80
Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood (2001) 2.57
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Med (2008) 2.43
Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet (1995) 2.42
Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire. Lancet (1997) 2.12
Is Africa lost? Lancet (1991) 2.08
Tuberculosis control in South Africa--time for a new paradigm? S Afr Med J (1996) 2.08
Provider-initiated HIV testing and counselling for TB patients and suspects in Nairobi, Kenya. Int J Tuberc Lung Dis (2008) 2.05
Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 2.02
Disease in children infected with HIV in Abidjan, Côte d'Ivoire. BMJ (1996) 1.92
Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am Rev Respir Dis (1992) 1.92
B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun (1998) 1.86
Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA (1994) 1.84
Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis (2011) 1.76
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med (2006) 1.73
Contribution of tuberculosis to slim disease in Africa. BMJ (1994) 1.73
HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS (2000) 1.65
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41. Antimicrob Agents Chemother (2005) 1.63
Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Infect Immun (2001) 1.60
Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells. Infect Immun (1999) 1.60
Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol (2000) 1.58
Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS (1997) 1.55
T cell activation and disease severity in HIV infection. Clin Exp Immunol (1993) 1.53
Notification of tuberculosis: an updated code of practice for England and Wales. J R Coll Physicians Lond (1997) 1.52
Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city. BMJ (1992) 1.51
Genetic diversity in human-derived Pneumocystis carinii isolates from four geographical locations shown by analysis of mitochondrial rRNA gene sequences. J Clin Microbiol (1994) 1.50
The growing challenge of HIV/AIDS in developing countries. Br Med Bull (1998) 1.48
Disease progression and survival in HIV-1-infected Africans in London. AIDS (1998) 1.47
Carcinoma of the penis in a HIV positive patient. Genitourin Med (1995) 1.47
Spectrum of disease in Africans with AIDS in London. AIDS (1996) 1.43
Crusted ("Norwegian") scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med (1996) 1.40
The Côte d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data. AIDS (1998) 1.39
Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol (2007) 1.39
Resurgence of tuberculosis. J Hosp Infect (1993) 1.38
Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic. AIDS (1998) 1.37
Isolation of mycobacteria from patients seropositive for the human immunodeficiency virus (HIV) in south east England: 1984-92. Thorax (1993) 1.34
Drug-resistant tuberculosis in South African gold miners: incidence and associated factors. Int J Tuberc Lung Dis (2000) 1.32
Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am J Trop Med Hyg (1996) 1.30
Intestinal inflammation, ileal structure and function in HIV. AIDS (1996) 1.29
Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis (2008) 1.28
Spectrum of disease among HIV-infected adults hospitalised in a respiratory medicine unit in Abidjan, Côte d'Ivoire. Int J Tuberc Lung Dis (1998) 1.25
HIV-1 and HIV-2 infections in men attending sexually transmitted disease clinics in Abidjan, Côte d'Ivoire. AIDS (1992) 1.23
Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J Respir Crit Care Med (1999) 1.22
A comparison of amebic and pyogenic abscess of the liver. Medicine (Baltimore) (1987) 1.21
The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. N Engl J Med (1988) 1.19
HIV/AIDS among African Americans: progress or progression? AIDS (2000) 1.18
Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in south east England: a recent increase in the number of cases. Arch Dis Child (1995) 1.18
Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med (1999) 1.17
Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa. AIDS (1993) 1.13
Isolation of environmental mycobacteria from clinical specimens in south-east England: 1973-1993. Int J Tuberc Lung Dis (1997) 1.13
Tuberculosis risk among staff of a large public hospital in Kenya. Int J Tuberc Lung Dis (2008) 1.11
Evaluation of simple diagnostic algorithms for Neisseria gonorrhoeae and Chlamydia trachomatis cervical infections in female sex workers in Abidjan, Côte d'Ivoire. Sex Transm Infect (1998) 1.11
Tuberculosis and HIV infection in children in Abidjan, Côte d'Ivoire. Trans R Soc Trop Med Hyg (1994) 1.11
Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire. AIDS (1997) 1.11
Clinical management of tuberculosis and HIV-1 co-infection. Eur Respir J (2010) 1.10
Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'Ivoire. Lancet (1992) 1.09
Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia. Infect Immun (2000) 1.09
Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection. HIV Med (2013) 1.08
Mycobacterial disease in South African gold miners in the era of HIV infection. Int J Tuberc Lung Dis (1999) 1.08
Tuberculosis control in resource-poor settings with high rates of HIV infection. Am J Public Health (1996) 1.06
Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte d'Ivoire. AIDS (1995) 1.05
Decreased IFN- gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis (Edinb) (2002) 1.04
Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002). Int J STD AIDS (2008) 1.04
The impact of HIV infection on recurrence of tuberculosis in South African gold miners. Int J Tuberc Lung Dis (2000) 1.04
Impact of the HIV epidemic on trends in tuberculosis in Abidjan, Côte d'Ivoire. Tuber Lung Dis (1995) 1.03
The molecular epidemiology of tuberculosis in inner London. Epidemiol Infect (2002) 1.03
Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med (1987) 1.03
The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast. Am J Obstet Gynecol (1995) 1.02
Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis (1999) 1.01
Oligomeric nature of transmembrane glycoproteins of HIV-2: procedures for their efficient dissociation and preparation of Western blots for diagnosis. AIDS (1991) 1.01
Cutting the cost of South African antiretroviral therapy using newer, safer drugs. S Afr Med J (2016) 1.01
Cell cycling in HIV infection: analysis of in vivo activated lymphocytes. Clin Exp Immunol (1995) 1.00
Efficacies of US Food and Drug Administration-licensed HIV-1-screening enzyme immunoassays for detecting antibodies to HIV-2. AIDS (1990) 0.99
Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histopathologic study with multiple liver biopsies. Hepatology (1986) 0.99
Fatal haemorrhage following liver biopsy in patients with HIV infection. Genitourin Med (1996) 0.98
Designing a vaccine for tuberculosis. BMJ (1996) 0.98
Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax (2011) 0.97
Disease progression and survival following specific AIDS-defining conditions: a retrospective cohort study of 2048 HIV-infected persons in London. AIDS (1998) 0.97
Salivary and urinary diagnosis of human immunodeficiency viruses 1 and 2 infection in Côte d'Ivoire, using two assays. Trans R Soc Trop Med Hyg (1993) 0.96
Delta agent superinfection. Rapidly progressive liver disease in a hepatitis B virus carrier. Arch Pathol Lab Med (1985) 0.96
ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey. Anaesthesia (1999) 0.96
Medical treatment of hepatic amebic abscess: rare need for percutaneous drainage. Radiology (1987) 0.95
AIDS: an old disease from Africa? Br Med J (Clin Res Ed) (1984) 0.94
Old plague, new plague, and a treatment for both? AIDS (1993) 0.93
Epidemiology of tuberculosis in the era of HIV. AIDS (1993) 0.93
Tuberculosis in the HIV-positive patient. Br J Hosp Med (1997) 0.93
Impact of different low-dose ritonavir regimens on lipids, CD36, and adipophilin expression. Clin Pharmacol Ther (2008) 0.93
HIV infection and Salmonella septic arthritis. Clin Exp Rheumatol (1993) 0.93
HIV-1 and HIV-2 infection associated with AIDS in Abidjan, Côte d'Ivoire. AIDS (1989) 0.92
A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience. Int J STD AIDS (2012) 0.92
Nocardiosis in HIV-positive patients: an autopsy study in West Africa. Tuber Lung Dis (1994) 0.91
Risk of cancer in patients with HIV disease. London African HIV/AIDS Study Group. Int J STD AIDS (1999) 0.91
Liver transplantation in adults coinfected with HIV. Transplantation (2001) 0.91